Organism name | Brassica oleracea |
---|---|
Genus | Brassica |
Family | Cruciferae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Brassica oleracea |
---|---|
Linked NCBI taxonomy ID | 3712 |
Linked level | species |
Family in NCBI taxonomy | Brassicaceae |
---|---|
ID | 3700 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Brassica oleracea L. var. gemmifera Zenker | Antiatherosclerotic |
Brassica oleracea L. var. gemmifera Zenker | Antimaculitic |
Brassica oleracea L. var. gemmifera Zenker | Antinitrosaminic |
Brassica oleracea L. var. gemmifera Zenker | Antinyctalopic |
Brassica oleracea L. var. gemmifera Zenker | Antioxidant |
Brassica oleracea L. var. gemmifera Zenker | Antiproliferant |
Brassica oleracea L. var. gemmifera Zenker | Antiradicular |
Brassica oleracea L. var. gemmifera Zenker | Antiretinitic |
Brassica oleracea L. var. gemmifera Zenker | Antitumor, breast |
Brassica oleracea L. var. gemmifera Zenker | Antitumor, colon |
Brassica oleracea L. var. gemmifera Zenker | Antitumor, lung |
Brassica oleracea L. var. gemmifera Zenker | Antitumor, skin |
Brassica oleracea L. var. gemmifera Zenker | Antiviral |
Brassica oleracea L. var. gemmifera Zenker | Detoxicant |
Brassica oleracea L. var. gemmifera Zenker | Estrogenic |
Brassica oleracea L. var. gemmifera Zenker | Glucuronidase-Inhibitor |
Brassica oleracea L. var. gemmifera Zenker | Goitrogenic |
Brassica oleracea L. var. gemmifera Zenker | Hypocholesterolemic |
Brassica oleracea L. var. gemmifera Zenker | Prooxidant |
Brassica oleracea L. var. gemmifera Zenker | Quinone-Reductase-Inducer |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00005646
![]() |
Patuletin 3-gentiobioside
/ Patuletin-3-O-beta-D-gentiobioside |
No. 1 | No. 15 |
![]() |
||||
C00006674
![]() |
Cyanidin 3-sophoroside-5-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00013766
![]() |
Kaempferol 3-sophoroside-7-cellobioside
/ 3-[(2-O-beta-D-Glucopyranosyl-beta-D-glucopyranosyl)oxy]-7-[(4-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 5 | No. 15 |
![]() |
||||
C00006841
![]() |
Cyanidin 3-(6''-malonylsophoroside)-5-glucoside
|
No. 5 | No. 15 |
![]() |
||||
C00005229
![]() |
(-)-Kaempferol 3-O-sophoroside 7-O-beta-D-glucopyranoside
/ Kaempferol 3-O-sophoroside 7-O-beta-D-glucopyranoside:Kaempferol 3-sophoroside-7-glucoside |
No. 5 | No. 15 |
![]() |
||||
C00005464
![]() |
Quercetin 3-sophoroside-7-glucoside
/ 2-(3,4-Dihydroxyphenyl)-3-[(2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-7-(beta-D-glucopyranosyloxy)-5-hydroxy-4H-1-benzopyran-4-one |
No. 5 | No. 15 |
![]() |
||||
C00005997
![]() |
Quercetin 3-[2'''-(E)-feruloylsophoroside]-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005912
![]() |
Kaempferol 3-(2'''-(E)-p-coumarylsophoroside)-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005996
![]() |
Quercetin 3-(2'''-(E)-caffeylsophoroside]-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005916
![]() |
Kaempferol 3-(2'''-sinapylsophoroside)-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005914
![]() |
Kaempferol 3-[2'''-(E)-ferulylsophoroside]-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006848
![]() |
Cyanidin 3-[6''-(4-glucosylferulyl)-sophoroside]-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006846
![]() |
Cyanidin 3-[6''-(4-glucosyl-p-coumaryl)sophoroside]-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00005913
![]() |
Kaempferol 3-(2'''-(E)-caffeylsophoroside)-7-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00013805
![]() |
Kaempferol 3-(2'''-(E)-caffeoylglucosyl)-(1->2)-glucoside-7-cellobioside
/ 3-[[2-O-[2-O-[(2E)-3-(3,4-Dihydroxyphenyl)-1-oxo-2-propenyl]-beta-D-glucopyranosyl]-beta-D-glucopyranosyl]oxy]-7-[(4-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]-5-hydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
No. 7 | No. 15 |
![]() |
||||
C00006842
![]() |
Cyanidin 3-(6''-p-coumarylsophoroside)-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006844
![]() |
Cyanidin 3-(6''-ferulylsophoroside)-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00006845
![]() |
Cyanidin 3-(6''-sinapylsophoroside)-5-glucoside
|
No. 7 | No. 15 |
![]() |
||||
C00007344
![]() |
Glucoerucin
/ 4-Methylthiobutyl glucosinolate |
C119493
|
No. 46 | No. 76 |
![]() |
|||
C00001488
![]() |
Sinigrin
/ Allyl glucosinolate / 2-Phenylethyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00007586
![]() |
Gluconapin
/ 3-Butyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00001486
![]() |
Progoitrin
/ 2(R)-2-Hydroxy 3-butenyl glucosinolate |
C009048
|
No. 46 | No. 76 |
![]() |
|||
C00001473
![]() |
Glucoiberverin
/ 3-(Methylthio)propyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00001463
![]() |
Glucobrassicanapin
/ 4-Pentenyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00007343
![]() |
Glucoiberin
/ 3-Methylsulfinylpropyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00007545
![]() |
Glucoraphanin
/ 4-Methylsulphinylbutyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00007864
![]() |
Epiprogoitrin
/ 2(S)-2-Hydroxy-3-butenyl glucosinolate |
No. 46 | No. 76 |
![]() |
||||
C00006853
![]() |
Cyanidin 3-(6''-ferulyl-2'''-sinapylsophoroside)-5-glucoside
|
No. 62 | No. 15 |
![]() |
||||
C00006851
![]() |
Cyanidin 3-(6''-p-coumaryl-2''-sinapylsophoroside)-5-glucoside
|
No. 62 | No. 15 |
![]() |
||||
C00006854
![]() |
Cyanidin 3-(6'',6'''-disinapylsophoroside)-5-glucoside
|
No. 62 | No. 15 |
![]() |
||||
C00001260
![]() |
Nonacosane
|
CHEMBL428955
|
C047577
|
No. 115 |
![]() |
|||
C00001255
![]() |
Hexacosanol
/ Hexacosan-1-ol |
C051942
|
0 / 2 | No. 115 |
![]() |
|||
C00001269
![]() |
n-Triacontanol
/ Triacontan-1-ol |
CHEMBL1079147
|
C047578
|
1 / 0 / 0 | No. 115 |
![]() |
||
C00007350
![]() |
Gluconasturtiin
/ 2-Phenylethylglucosinolate |
C443697
|
No. 158 | No. 77 |
![]() |
|||
C00000127
![]() |
4-Hydroxyglucobrassicin
/ 4-Hydroxy-3-indolylmethylglucosinolate |
C036021
|
No. 158 | No. 77 |
![]() |
|||
C00000125
![]() |
Glucobrassicin
/ Glucobrassicine / 3-Indolylmethylglucosinolate |
C048308
|
2 / 0 | No. 158 | No. 77 |
![]() |
||
C00000126
![]() |
Neoglucobrassicin
/ 1-Methoxy-3-indolylmethylglucosinolate |
C064701
|
2 / 0 | No. 158 | No. 77 |
![]() |
||
C00000107
![]() |
IAN
/ Indole-3-acetonitrile |
CHEMBL1812654
|
C016516
|
No. 710 | No. 4 |
![]() |
||
C00000096
![]() |
9-Ribosyl-trans-zeatin
/ Zeatin-9-beta-D-ribofuranoside |
No. 989 |
![]() |
|||||
C00000097
![]() |
N6-(D2-Isopentenyl)-2-methylthioadenosine
/ 2-Methylthio-N6-(delta2-isopentenyl)adenosine |
C008503
|
No. 989 |
![]() |
||||
C00002776
![]() |
Sinapic acid
|
CHEMBL109341
|
C073734
|
5 / 5 / 5 | 0 / 5 | No. 1366 | No. 6 |
![]() |
C00000100
![]() |
IAA
/ Indole-3-acetic acid |
CHEMBL82411
|
C030737
|
3 / 0 / 0 | 2 / 1 | No. 1432 | No. 4 |
![]() |
C00050239
![]() |
Sulforaphane
|
CHEMBL48802
CHEMBL128136 CHEMBL1627201 |
C016766
|
5 / 3 / 4 | 98 / 10 | No. 2731 |
![]() |
|
C00033745
![]() |
Cyclobrassinin
|
No. 3628 |
![]() |
|||||
C00036440
![]() |
1-Methoxyspirobrassinin
/ (+)-1-Methoxyspirobrassinin |
No. 3637 |
![]() |
|||||
C00001546
![]() |
Methoxybrassinin
/ 1-Methoxybrassinin |
No. 3839 |
![]() |
|||||
C00027106
![]() |
Brassinin
|
CHEMBL373777
CHEMBL1673034 CHEMBL1673036 CHEMBL1673037 |
C089020
|
5 / 7 / 10 | No. 3839 |
![]() |
||
C00036583
![]() |
4-Methoxybrassinin
|
No. 3839 |
![]() |
|||||
C00001151
![]() |
Sucrose
/ (+)-Sucrose |
CHEMBL253582
CHEMBL1976550 |
D013395
|
1 / 0 / 0 | 4 / 10 | No. 3949 |
![]() |
|
C00000101
![]() |
IAA methyl ester
/ Methyl indole-3-acetate |
No. 4225 |
![]() |
|||||
C00000112
![]() |
Indole-3-carboxaldehyde
/ 1H-Indole-3-carboxaldehyde |
CHEMBL147741
|
C012381
|
2 / 1 / 1 | No. 4314 |
![]() |
||
C00027108
![]() |
Brassilexin
|
C430121
|
No. 5488 |
![]() |
||||
C00027107
![]() |
Brassicanal A
|
No. 5537 |
![]() |
|||||
C00037061
![]() |
Dioxibrassinin
/ (-)-Dioxibrassinin |
No. 6903 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P02768 | Serum albumin | Secreted protein | C00000100 C00001151 | 0 / 0 |
P14902 | Indoleamine 2,3-dioxygenase 1 | Enzyme | C00027106 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00002776 | 3 / 0 |
Q16773 | Kynurenine--oxoglutarate transaminase 1 | Enzyme | C00000100 | 0 / 0 |
P12268 | Inosine-5'-monophosphate dehydrogenase 2 | Oxidoreductase | C00000112 | 0 / 0 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00001269 | 0 / 0 |
P15559 | NAD(P)H dehydrogenase [quinone] 1 | Enzyme | C00050239 | 0 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00050239 | 2 / 3 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00002776 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00002776 | 2 / 2 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00002776 | 0 / 3 |
Q9HBH1 | Peptide deformylase, mitochondrial | Enzyme | C00000100 | 0 / 0 |
Q92887 | Canalicular multispecific organic anion transporter 1 | Unclassified protein | C00050239 | 1 / 1 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000112 | 1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00050239 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00027106 | 4 / 3 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00050239 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00027106 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00027106 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00027106 | 1 / 2 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002776 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00000100
C00050239
|
1728 | NQO1, DHQU, DIA4, DTD, NMOR1, NMORI, QR1 | NAD(P)H dehydrogenase, quinone 1 (EC:1.6.5.2) |
C00000125
C00050239
|
710 | SERPING1, C1IN, C1INH, C1NH, HAE1, HAE2 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
C00050239
|
1244 | ABCC2, ABC30, CMOAT, DJS, MRP2, cMRP | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 |
C00050239
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00050239
|
216 | ALDH1A1, ALDC, ALDH-E1, ALDH1, ALDH11, PUMB1, RALDH1 | aldehyde dehydrogenase 1 family, member A1 (EC:1.2.1.36) |
C00050239
|
367 | AR, AIS, DHTR, HUMARA, HYSP1, KD, NR3C4, SBMA, SMAX1, TFM | androgen receptor |
C00050239
|
506 | ATP5B, ATPMB, ATPSB | ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide (EC:3.6.3.14) |
C00050239
|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00050239
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00050239
|
598 | BCL2L1, BCL-XL/S, BCL2L, BCLX, BCLXL, BCLXS, Bcl-X, PPP1R52, bcl-xL, bcl-xS | BCL2-like 1 |
C00050239
|
826 | CAPNS1, 30K, CALPAIN4, CANP, CANPS, CAPN4, CDPS, CSS1 | calpain, small subunit 1 (EC:3.4.22.17) |
C00050239
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00050239
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00050239
|
874 | CBR3, SDR21C2, hCBR3 | carbonyl reductase 3 (EC:1.1.1.184) |
C00050239
|
891 | CCNB1, CCNB | cyclin B1 |
C00050239
|
10576 | CCT2, 99D8.1, CCT-beta, CCTB, PRO1633, TCP-1-beta | chaperonin containing TCP1, subunit 2 (beta) |
C00050239
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00050239
|
1066 | CES1, ACAT, CE-1, CEH, CES2, HMSE, HMSE1, PCE-1, REH, SES1, TGH, hCE-1 | carboxylesterase 1 (EC:3.1.1.1 3.1.1.56) |
C00050239
|
8452 | CUL3, CUL-3, PHA2E | cullin 3 |
C00050239
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00050239
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00050239
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00050239
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00050239
|
1674 | DES, CSM1, CSM2, LGMD2R | desmin |
C00050239
|
1984 | EIF5A, EIF-5A, EIF5A1, eIF5AI | eukaryotic translation initiation factor 5A |
C00050239
|
2072 | ERCC4, ERCC11, FANCQ, RAD1, XPF | excision repair cross-complementing rodent repair deficiency, complementation group 4 |
C00050239
|
2073 | ERCC5, COFS3, ERCM2, UVDR, XPG, XPGC | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
C00050239
|
2078 | ERG, erg-3, p55 | v-ets avian erythroblastosis virus E26 oncogene homolog |
C00050239
|
1647 | GADD45A, DDIT1, GADD45 | growth arrest and DNA-damage-inducible, alpha |
C00050239
|
2729 | GCLC, GCL, GCS, GLCL, GLCLC | glutamate-cysteine ligase, catalytic subunit (EC:6.3.2.2) |
C00050239
|
2730 | GCLM, GLCLR | glutamate-cysteine ligase, modifier subunit (EC:6.3.2.2) |
C00050239
|
2936 | GSR | glutathione reductase (EC:1.8.1.7) |
C00050239
|
2938 | GSTA1, GST2, GSTA1-1, GTH1 | glutathione S-transferase alpha 1 (EC:2.5.1.18) |
C00050239
|
2944 | GSTM1, GST1, GSTM1-1, GSTM1a-1a, GSTM1b-1b, GTH4, GTM1, H-B, MU, MU-1 | glutathione S-transferase mu 1 (EC:2.5.1.18) |
C00050239
|
2950 | GSTP1, DFN7, FAEES3, GST3, GSTP, PI | glutathione S-transferase pi 1 (EC:2.5.1.18) |
C00050239
|
2952 | GSTT1 | glutathione S-transferase theta 1 (EC:2.5.1.18) |
C00050239
|
10013 | HDAC6, CPBHM, HD6 | histone deacetylase 6 (EC:3.5.1.98) |
C00050239
|
221613 | HIST1H2AA, H2AA, H2AFR, bA317E16.2 | histone cluster 1, H2aa |
C00050239
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00050239
|
3185 | HNRNPF, HNRPF, OK/SW-cl.23, mcs94-1 | heterogeneous nuclear ribonucleoprotein F |
C00050239
|
3187 | HNRNPH1, HNRPH, HNRPH1, hnRNPH | heterogeneous nuclear ribonucleoprotein H1 (H) |
C00050239
|
3190 | HNRNPK, CSBP, HNRPK, TUNP | heterogeneous nuclear ribonucleoprotein K |
C00050239
|
3320 | HSP90AA1, EL52, HSP86, HSP89A, HSP90A, HSP90N, HSPC1, HSPCA, HSPCAL1, HSPCAL4, HSPN, Hsp89, Hsp90, LAP2 | heat shock protein 90kDa alpha (cytosolic), class A member 1 |
C00050239
|
3305 | HSPA1L, HSP70-1L, HSP70-HOM, HSP70T, hum70t | heat shock 70kDa protein 1-like |
C00050239
|
3308 | HSPA4, APG-2, HS24/P52, HSPH2, RY, hsp70, hsp70RY | heat shock 70kDa protein 4 |
C00050239
|
3313 | HSPA9, CSA, GRP-75, GRP75, HSPA9B, MOT, MOT2, MTHSP75, PBP74 | heat shock 70kDa protein 9 (mortalin) |
C00050239
|
3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00050239
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00050239
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00050239
|
9118 | INA, NEF5, NF-66, TXBP-1 | internexin neuronal intermediate filament protein, alpha |
C00050239
|
9817 | KEAP1, INrf2, KLHL19 | kelch-like ECH-associated protein 1 |
C00050239
|
354 | KLK3, APS, KLK2A1, PSA, hK3 | kallikrein-related peptidase 3 (EC:3.4.21.77) |
C00050239
|
3956 | LGALS1, GAL1, GBP | lectin, galactoside-binding, soluble, 1 |
C00050239
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00050239
|
5602 | MAPK10, JNK3, JNK3A, PRKM10, SAPK1b, p493F12, p54bSAPK | mitogen-activated protein kinase 10 (EC:2.7.11.24) |
C00050239
|
1432 | MAPK14, CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2, PRKM14, PRKM15, RK, SAPK2A, p38, p38ALPHA | mitogen-activated protein kinase 14 (EC:2.7.11.24) |
C00050239
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00050239
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00050239
|
5601 | MAPK9, JNK-55, JNK2, JNK2A, JNK2ALPHA, JNK2B, JNK2BETA, PRKM9, SAPK, SAPK1a, p54a, p54aSAPK | mitogen-activated protein kinase 9 (EC:2.7.11.24) |
C00050239
|
4255 | MGMT | O-6-methylguanine-DNA methyltransferase (EC:2.1.1.63) |
C00050239
|
4489 | MT1A, MT1, MT1S, MTC | metallothionein 1A |
C00050239
|
4502 | MT2A, MT2 | metallothionein 2A |
C00050239
|
10397 | NDRG1, CAP43, CMT4D, DRG-1, DRG1, GC4, HMSNL, NDR1, NMSL, PROXY1, RIT42, RTP, TARG1, TDD5 | N-myc downstream regulated 1 |
C00050239
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00050239
|
4830 | NME1, AWD, GAAD, NB, NBS, NDKA, NDPK-A, NDPKA, NM23, NM23-H1 | NME/NM23 nucleoside diphosphate kinase 1 (EC:2.7.4.6) |
C00050239
|
283458 |
C00050239
|
||
4851 | NOTCH1, TAN1, hN1 | notch 1 |
C00050239
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00050239
|
8856 | NR1I2, BXR, ONR1, PAR, PAR1, PAR2, PARq, PRR, PXR, SAR, SXR | nuclear receptor subfamily 1, group I, member 2 |
C00050239
|
5034 | P4HB, DSI, ERBA2L, GIT, P4Hbeta, PDI, PDIA1, PHDB, PO4DB, PO4HB, PROHB | prolyl 4-hydroxylase, beta polypeptide (EC:5.3.4.1) |
C00050239
|
5111 | PCNA | proliferating cell nuclear antigen |
C00050239
|
10935 | PRDX3, AOP-1, AOP1, HBC189, MER5, PRO1748, SP-22, prx-III | peroxiredoxin 3 (EC:1.11.1.15) |
C00050239
|
5630 | PRPH, NEF4, PRPH1 | peripherin |
C00050239
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00050239
|
5928 | RBBP4, NURF55, RBAP48 | retinoblastoma binding protein 4 |
C00050239
|
5966 | REL, C-Rel | v-rel avian reticuloendotheliosis viral oncogene homolog |
C00050239
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00050239
|
3921 | RPSA, 37LRP, 67LR, LAMBR, LAMR1, LBP, LBP/p40, LRP, LRP/LR, NEM/1CHD4, SA, lamR, p40 | ribosomal protein SA |
C00050239
|
60 | ACTB, BRWS1, PS1TP5BP1 | actin, beta |
C00050239
|
2810 | SFN, YWHAS | stratifin |
C00050239
|
29986 | SLC39A2, 6A1, ETI-1, ZIP-2, ZIP2 | solute carrier family 39 (zinc transporter), member 2 |
C00050239
|
1155 | TBCB, CG22, CKAP1, CKAPI | tubulin folding cofactor B |
C00050239
|
7168 | TPM1, C15orf13, CMD1Y, CMH3, HTM-alpha, LVNC9, TMSA | tropomyosin 1 (alpha) |
C00050239
|
7846 | TUBA1A, B-ALPHA-1, LIS3, TUBA3 | tubulin, alpha 1a |
C00050239
|
113457 | TUBA3D, H2-ALPHA | tubulin, alpha 3d |
C00050239
|
7277 | TUBA4A, H2-ALPHA, TUBA1 | tubulin, alpha 4a |
C00050239
|
81027 | TUBB1 | tubulin, beta 1 class VI |
C00050239
|
100691897 |
C00050239
|
||
7295 | TXN, TRDX, TRX, TRX1 | thioredoxin |
C00050239
|
7296 | TXNRD1, GRIM-12, TR, TR1, TRXR1, TXNR | thioredoxin reductase 1 (EC:1.8.1.9) |
C00050239
|
54658 | UGT1A1, BILIQTL1, GNT1, HUG-BR1, UDPGT, UDPGT_1-1, UGT1, UGT1A | UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) |
C00050239
|
7415 | VCP, ALS14, IBMPFD, IBMPFD1, TERA, p97 | valosin containing protein (EC:3.6.4.6) |
C00050239
|
7431 | VIM, CTRCT30 | vimentin |
C00050239
|
7529 | YWHAB, GW128, HS1, KCIP-1, YWHAA | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
C00050239
|
7531 | YWHAE, 14-3-3E, KCIP-1, MDCR, MDS | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
C00050239
|
10971 | YWHAQ, 14-3-3, 1C5, HS1 | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide |
C00050239
|
353088 | ZNF429 | zinc finger protein 429 |
C00050239
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00000100
|
2877 | GPX2, GI-GPx, GPRP, GPRP-2, GPx-2, GPx-GI, GSHPX-GI, GSHPx-2 | glutathione peroxidase 2 (gastrointestinal) (EC:1.11.1.9) |
C00000125
|
3251 | HPRT1, HGPRT, HPRT | hypoxanthine phosphoribosyltransferase 1 (EC:2.4.2.8) |
C00000126
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000126
|
3630 | INS, IDDM2, ILPR, IRDN, MODY10 | insulin |
C00001151
|
55630 | SLC39A4, AEZ, AWMS2, ZIP4 | solute carrier family 39 (zinc transporter), member 4 |
C00001151
|
80834 | TAS1R2, GPR71, T1R2, TR2 | taste receptor, type 1, member 2 |
C00001151
|
83756 | TAS1R3, T1R3 | taste receptor, type 1, member 3 |
C00001151
|
OMIM | preferred title | UniProt |
---|---|---|
#600807 | Asthma, susceptibility to |
Q13093
|
#237500 | Dubin-johnson syndrome; djs |
Q92887
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
|
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00017 | Esophageal cancer |
P35354
(related)
|
H00025 | Penile cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00208 | Hyperbilirubinemia |
Q92887
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D056486 | Drug-Induced Liver Injury |
C00050239
C00000100 C00002776 |
D003928 | Diabetic Nephropathies |
C00050239
C00001255 |
D000860 | Anoxia |
C00002776
|
D006528 | Carcinoma, Hepatocellular |
C00050239
|
D058186 | Acute Kidney Injury |
C00050239
|
D011125 | Adenomatous Polyposis Coli |
C00050239
|
D009336 | Necrosis |
C00050239
|
D009369 | Neoplasms |
C00050239
|
D011041 | Poisoning |
C00050239
|
D002583 | Uterine Cervical Neoplasms |
C00050239
|
D001745 | Urinary Bladder Diseases |
C00001255
|
D000647 | Amnesia |
C00002776
|
D001327 | Autoimmune Diseases |
C00050239
|
D001930 | Brain Injuries |
C00002776
|
D004487 | Edema |
C00002776
|
D019969 | Amphetamine-Related Disorders |
C00001151
|
D018149 | Glucose Intolerance |
C00001151
|
D006461 | Hemolysis |
C00001151
|
D006946 | Hyperinsulinism |
C00001151
|
D006948 | Hyperkinesis |
C00001151
|
D006973 | Hypertension |
C00001151
|
D007333 | Insulin Resistance |
C00001151
|
D009401 | Nephrosis |
C00001151
|
C541083 | Non-alcoholic Fatty Liver Disease |
C00001151
|
D019966 | Substance-Related Disorders |
C00001151
|